UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003897
Receipt number R000004647
Scientific Title Evaluation of efficacy and safety of fluoroquinolone in patients with nongonococcal urethritis
Date of disclosure of the study information 2010/07/31
Last modified on 2010/07/03 01:30:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of efficacy and safety of fluoroquinolone in patients with nongonococcal urethritis

Acronym

Evaluation of efficacy and safety of fluoroquinolone in patients with nongonococcal urethritis

Scientific Title

Evaluation of efficacy and safety of fluoroquinolone in patients with nongonococcal urethritis

Scientific Title:Acronym

Evaluation of efficacy and safety of fluoroquinolone in patients with nongonococcal urethritis

Region

Japan


Condition

Condition

nongonococcal urethritis (Chlamydia trachomatis urethritis, Mycoplasma genitalium urethritis)

Classification by specialty

Infectious disease Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We evaluate efficacy and safety of levofloxacin 500mg administered orally once daily in patients with nongonococcal urethritis

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

bacteriological efficacy two weeks after the end of treatment by levoflixacin

Key secondary outcomes

clinical efficacy two weeks after the end of treatment by levofloxacin


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

levofloxacin 500mg once daily p.o. 7days

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

1)age: more than 20 years old
2)sex: male
3)outpatient or hospitalization: both are included
4)patient with suspicious symptoms of nongonococcal urethritis
5)patient detected C. trachomatis or M. genitalium by bacteriological examination

Key exclusion criteria

1)patient detected N.gonorrhoeae by microscopic examination or bacteriological examination etc.
2)patient who has been administered other antibiotics and his symptom has been improved before starting administration of the study drug
3)patient administered fluoroquinolone within a week before starting administration of the study drug
4)patient with severe infection desease, who cannot be expected efficacy of oral administration therapy
5)patient with severe underlying disease or complications, who cannot be evaluated efficacy and safety of the study drug
6)patient with a history of fluoroquinolone allergies
7)patient with severe cardiac or hepatic dysfunction
8)patient with moderate renal dysfunction (Criteria: Serum Creatinine >= 2mg/dL)
9)patient with convulsive disorders like epilepsy or with a history of these deseases
10)patient disqualified as target by doctor

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shoichi Onodera

Organization

Jikei University School of Medicine

Division name

Department of Infectious Diseases and Infection Control

Zip code


Address

3-25-8 Nishi-Shimbashi Minato-ku Tokyo Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Jikei University School of Medicine

Division name

Department of Infectious Diseases and Infection Control

Zip code


Address

3-25-8 Nishi-Shimbashi Minato-ku Tokyo Japan

TEL


Homepage URL


Email



Sponsor or person

Institute

Department of Infectious Diseases and Infection Control, Jikei University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Infectious Diseases and Infection Control, Jikei University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京慈恵会医科大学附属病院(東京都)


Other administrative information

Date of disclosure of the study information

2010 Year 07 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2010 Year 06 Month 30 Day

Date of IRB


Anticipated trial start date

2010 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 07 Month 09 Day

Last modified on

2010 Year 07 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004647


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name